Vicks Sinex Severe Congestion Spray
NDC Package 64336-005-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Vicks Sinex Severe Congestion (oxymetazoline hydrochloride) sprays is remove protective cap. This formulation utilizes a spray delivery system. Marketed by Procter & Gamble Manufacturing Gmbh, this product is identified by NDC 64336-005 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
64336-005-01
Package Description
1 BOTTLE, SPRAY in 1 CARTON / 15 mL in 1 BOTTLE, SPRAY
Product Code
64336-005
11-Digit Billing Format
64336000501
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Vicks Sinex Severe Congestion Vapocool Ultra Fine Mist
Non-Proprietary Name
Oxymetazoline Hydrochloride
Substance Name
Oxymetazoline Hydrochloride
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Nasal - Administration to the nose; administered by way of the nose.
Active Ingredient(s)
OXYMETAZOLINE HYDROCHLORIDE .0005 g/mL
Pharmacologic Class
Usage Information
Remove protective cap. Before using for the first time, prime the pump by firmly depressing its rim several times. Hold container with thumb at base and nozzle between first and second fingers. Without tilting your head, inset nozzle into nostril. Fully depress rim with a firm, even stroke and inhale deeply.adults & children 6 yrs. & older (with adult supervision)2 or 3 sprays in each nostril, not more often than every 10 to 12 hours. Do not exceed 2 doses in 24 hours.children 2 to under 6 yrs.ask a doctorchildren under 2 yrs.do not use

Regulatory & Marketing

Labeler Name
Procter & Gamble Manufacturing Gmbh
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-27-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64336-005-01 identifies a specific commercial package of 1 bottle, spray in 1 carton / 15 ml in 1 bottle, spray of Vicks Sinex Severe Congestion Vapocool Ultra Fine Mist, a human over the counter drug labeled by Procter & Gamble Manufacturing Gmbh. This spray is formulated for nasal use and contains oxymetazoline hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Procter & Gamble Manufacturing Gmbh on February 27, 2026. The current certification is valid through December 31, 2027.

How is this Procter & Gamble Manufacturing Gmbh product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64336000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
64336-005-01
11-Digit CMS (5-4-2)
64336-0005-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.